Search research articles
Contact Us
Filters
Showing results (11-20 of 278) with videos related to
Page
of 28
Sort By:
European Urology
|
September 14, 2025
Predicting Urinary Toxicity After Prostate Stereotactic Body Radiotherapy: A Step Towards More Personalized Treatment
Jonathan E Leeman, Jason A Efstathiou
European Urology
|
August 7, 2024
Honing Stratification and Treatment for High-risk Prostate Cancer
Sophia C Kamran, Jason A Efstathiou
Current Urology Reports
|
April 3, 2013
Proton beam radiation therapy for prostate cancer-is the hype (and the cost) justified?
Phillip J Gray, Jason A Efstathiou
International Journal of Radiation Oncology, Biology, Physics
|
February 5, 2026
Tipping the Scales for Bladder Cancer: Weighing Differences in Quality of Life After Cystectomy Versus Trimodality Therapy
Kimberley S Mak, Jason A Efstathiou
Urologic Oncology
|
December 12, 2018
Proton therapy for prostate cancer: A review of the rationale, evidence, and current state
Trevor J Royce, Jason A Efstathiou
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2024
Adjuvant Radiation Therapy for Locally Advanced Bladder Cancer: A Safe and Promising Emerging Treatment Option
Brian C Baumann, Jason A Efstathiou
Frontiers in Oncology
|
May 24, 2021
Current State of Personalized Genitourinary Cancer Radiotherapy in the Era of Precision Medicine
Sophia C Kamran, Jason A Efstathiou
JAMA Oncology
|
November 14, 2018
Comparing Adjuvant vs Early-Salvage Radiotherapy After Radical Prostatectomy-Reply
William L Hwang, Andrzej Niemierko, Jason A Efstathiou
International Journal of Radiation Oncology, Biology, Physics
|
December 20, 2018
Safeguarding Autonomy of Patients With Bladder Cancer
Divya Yerramilli, Drew M Moghanaki, Jason A Efstathiou
Nature Reviews. Clinical Oncology
|
November 21, 2012
Urological cancer. The benefits of intermittent androgen-deprivation therapy
Timur Mitin, Jason A Efstathiou, William U Shipley
Page
of 28
Search research articles
Search
Showing results (11-20 of 278) with videos related to
Sort By:
Page
of 28
European Urology
|
September 14, 2025
Predicting Urinary Toxicity After Prostate Stereotactic Body Radiotherapy: A Step Towards More Personalized Treatment
Jonathan E Leeman, Jason A Efstathiou
European Urology
|
August 7, 2024
Honing Stratification and Treatment for High-risk Prostate Cancer
Sophia C Kamran, Jason A Efstathiou
Current Urology Reports
|
April 3, 2013
Proton beam radiation therapy for prostate cancer-is the hype (and the cost) justified?
Phillip J Gray, Jason A Efstathiou
International Journal of Radiation Oncology, Biology, Physics
|
February 5, 2026
Tipping the Scales for Bladder Cancer: Weighing Differences in Quality of Life After Cystectomy Versus Trimodality Therapy
Kimberley S Mak, Jason A Efstathiou
Urologic Oncology
|
December 12, 2018
Proton therapy for prostate cancer: A review of the rationale, evidence, and current state
Trevor J Royce, Jason A Efstathiou
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2024
Adjuvant Radiation Therapy for Locally Advanced Bladder Cancer: A Safe and Promising Emerging Treatment Option
Brian C Baumann, Jason A Efstathiou
Frontiers in Oncology
|
May 24, 2021
Current State of Personalized Genitourinary Cancer Radiotherapy in the Era of Precision Medicine
Sophia C Kamran, Jason A Efstathiou
JAMA Oncology
|
November 14, 2018
Comparing Adjuvant vs Early-Salvage Radiotherapy After Radical Prostatectomy-Reply
William L Hwang, Andrzej Niemierko, Jason A Efstathiou
International Journal of Radiation Oncology, Biology, Physics
|
December 20, 2018
Safeguarding Autonomy of Patients With Bladder Cancer
Divya Yerramilli, Drew M Moghanaki, Jason A Efstathiou
Nature Reviews. Clinical Oncology
|
November 21, 2012
Urological cancer. The benefits of intermittent androgen-deprivation therapy
Timur Mitin, Jason A Efstathiou, William U Shipley
Page
of 28